Systemic immune system alterations in early stages of Alzheimer's disease. - Wikidata - awgldk - TriplyDB

Systemic immune system alterations in early stages of Alzheimer's disease.

Systemic immune system alterations in early stages of Alzheimer's disease.

http://www.wikidata.org/entity/Q36810980

about

Nutrients, Microglia Aging, and Brain Aging Neuroinflammation in Alzheimer's disease: chemokines produced by astrocytes and chemokine receptors A deficiency in CCR2+ monocytes: the hidden side of Alzheimer's disease Arginine deprivation and immune suppression in a mouse model of Alzheimer's disease Anti-Viral Properties of Amyloid-β Peptides.Reduced cerebrospinal fluid concentration of interleukin-12/23 subunit p40 in patients with cognitive impairment.Chronic intermittent hypoxia induces oxidative stress and inflammation in brain regions associated with early-stage neurodegeneration.A Novel Method to Identify Differential Pathways in Hippocampus Alzheimer's Disease Perioperative frailty Possible protective role of the 489C>T P2X7R polymorphism in Alzheimer's disease.Effects of storage conditions on the stability of serum CD163, NGAL, HMGB1 and MIP2 Myeloid dendritic cells are decreased in peripheral blood of Alzheimer's disease patients in association with disease progression and severity of depressive symptoms.Serum IL-8 is a marker of white-matter hyperintensities in patients with Alzheimer's disease.Role of neuroinflammation in neurodegeneration: new insights The Potential Role of Chemokines in Alzheimer's Disease Pathogenesis.Chronic functional bowel syndrome enhances gut-brain axis dysfunction, neuroinflammation, cognitive impairment, and vulnerability to dementia.The dynamics of monocytes and microglia in Alzheimer's disease.Proteome characterization of splenocytes from an Aβpp/ps-1 Alzheimer's disease model."Boomerang Neuropathology" of Late-Onset Alzheimer's Disease is Shrouded in Harmful "BDDS": Breathing, Diet, Drinking, and Sleep During Aging.Relationships Between Mitochondria and Neuroinflammation: Implications for Alzheimer's Disease.Protective Effect of Amyloid-β Peptides Against Herpes Simplex Virus-1 Infection in a Neuronal Cell Culture Model.Common neurodegenerative pathways in obesity, diabetes, and Alzheimer's disease.Glial biomarkers in human central nervous system disease.Clearance of cerebral Aβ in Alzheimer's disease: reassessing the role of microglia and monocytes.Extensive Association of Common Disease Variants with Regulatory Sequence.Identification of oxidative modifications of hemopexin and their predicted physiological relevance.Comparative profiling of cortical gene expression in Alzheimer's disease patients and mouse models demonstrates a link between amyloidosis and neuroinflammation.Plasma MCP-1 and Cognitive Decline in Patients with Alzheimer's Disease and Mild Cognitive Impairment: A Two-year Follow-up Study.Serum Protein-Based Profiles as Novel Biomarkers for the Diagnosis of Alzheimer's Disease.SB203580 reverses memory deficits and depression-like behavior induced by microinjection of Aβ1-42 into hippocampus of mice.Paeoniflorin Atttenuates Amyloidogenesis and the Inflammatory Responses in a Transgenic Mouse Model of Alzheimer's Disease.MCP-1 and CCR2 gene polymorphisms in Parkinson's disease in a Han Chinese cohort.Mutual effect of cerebral amyloid β and peripheral lymphocytes in cognitively normal older individuals.Methylglyoxal-bis-guanylhydrazone inhibits osteopontin expression and differentiation in cultured human monocytes.gene variation and microglial activity on [C]PBR28 PET in older adults at risk for Alzheimer's disease

P2860

Q26768461-ADF5FF96-F25B-492B-9C55-36C6016014D4 Q26995483-9B70033C-D19A-4503-9262-9D195BFCC5C9 Q26997058-51ECE296-5D4E-4FD9-8304-EDDA1FC1672B Q28391826-B3F7E29E-2467-4536-A3C2-A462AE5A4DEA Q30390299-6BCBF5AA-CB64-47F7-813D-E80ADE700B69 Q33626656-1B8061B5-D2A0-4F3B-97FF-BEA9F268BFBB Q33679761-E14C637F-D3A1-45BF-97A1-A05E571894F4 Q33702839-7C106389-42C7-405F-A2D1-7DAD3D676DB1 Q34278764-BA1AF313-4AA2-4C12-8FF0-9F9FC582F80F Q34702157-CB3E0A09-86C3-45E9-BF0B-E27B9D52B888 Q35741156-7AAC61D3-1856-4388-B1A0-22BC835A78C3 Q36503723-8163C595-0B1C-441F-B48A-29CC96977B0E Q37654102-4359ECB7-F87C-42CE-95E0-59DAD626CF1F Q37680099-02F84B46-F5EC-46F5-B6A0-A8ABF1CACED1 Q38177234-CC9E775E-837A-4BFC-8A03-4276CA6B58DD Q38192977-8875BE26-31BF-4F2B-9EFC-1289D45181C4 Q38423147-A8E4A26F-C304-4F97-A08D-0E53424025CD Q38440340-AC76017B-A58C-4A34-8E9C-44D97057A32B Q38441500-71FADBD6-063C-4F83-9F32-8F03758CA723 Q38574670-8BDEF698-43B1-425D-867D-086A87DE2CA5 Q38797410-3BF32CB0-5DEB-4862-A5B2-0C84B10BDAE1 Q38828830-F25670B0-FD66-42F9-A503-D7391C7836ED Q38845041-BD6BF949-DE05-4C0C-972B-8406E9209ADC Q39135845-4B091419-4819-479E-A7DC-34D32C19880B Q40462197-80F3E8DA-79FD-44D2-B6C1-5B3AFA61F303 Q46353874-BF68A276-AEFC-43AA-A8AE-05B4D802B562 Q47105056-F033363F-6DED-485C-9645-6B6751E55E96 Q47553904-A3D6DBCA-89C2-4B34-B877-CE0B97748948 Q47822179-5E82BFDB-2533-45B9-99ED-398DFABCED73 Q48046432-52A63F82-6834-4625-A373-A024CC0E9E4C Q48132377-A6DE82FC-1246-4ADC-9DA3-DE58330A939F Q48180975-122EA61A-7D91-44F3-93EC-C90E0FD158BD Q48325665-7CDFA884-CEAC-45DE-A3AB-28ABDEE6EF0E Q55256802-6DDA6191-7883-4FE6-95A2-899244623FA9 Q56989585-589EA904-9D62-4EEF-ABA9-D3F8CDB6263E

P2860

Systemic immune system alterations in early stages of Alzheimer's disease.

http://www.wikidata.org/entity/Q36810980

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Systemic immune system alterations in early stages of Alzheimer's disease.

@ast

Systemic immune system alterations in early stages of Alzheimer's disease.

@en

type

label

Systemic immune system alterations in early stages of Alzheimer's disease.

@ast

Systemic immune system alterations in early stages of Alzheimer's disease.

@en

prefLabel

Systemic immune system alterations in early stages of Alzheimer's disease.

@ast

Systemic immune system alterations in early stages of Alzheimer's disease.

@en

P1433

Q36810980-58DCDE86-F3A8-4C1B-BD3C-77A0D93AAADC

P1476

Q36810980-E66CF46D-B6B2-451B-8295-A664DEF78D52

P2093

Q36810980-26513E21-E367-47BA-9627-A55EE43E7E11

Q36810980-41B81854-595D-4D02-AF38-38598F3A99F5

Q36810980-436E9E66-0F95-4009-82CC-91778504A381

Q36810980-5A426926-48B1-4D45-B435-400EF00F1263

Q36810980-8259A887-3D3F-4734-B29D-5F4558CFF8BF

Q36810980-874210EA-1794-4CA9-B454-BBCBC490FFD1

Q36810980-A95B45D0-1C8F-421C-9A68-95B6F6CF2E43

Q36810980-BBC47B59-CC00-4B5B-93AE-B17FE9BF7299

Q36810980-F17CD5EE-5C07-4401-A1C7-751F79542294

P2860

Q36810980-0C1E3509-18C9-478F-BA06-35B033C914EC

Q36810980-11CB0BC1-80E3-488E-8862-11512DFF8721

Q36810980-131C2484-BF06-427E-A342-C8C7BFCFDD9F

Q36810980-1761678E-AD25-4814-873A-8B3FF8F97787

Q36810980-17A63FD6-AE4C-4C4E-A54C-0AB1B21944B0

Q36810980-1D99A862-6488-4A85-88CC-DF37A0FD94AF

Q36810980-2577141B-E565-4173-985D-0ACBF3E86148

Q36810980-2DBE77AA-425F-4E58-9B5F-BCC8A799870C

Q36810980-35A140B4-E740-478E-9492-0307DCEF0F0E

Q36810980-3735C8CD-3547-47A1-BD6F-A3407315241D

P304

Q36810980-FCBCC868-9773-449C-BBD3-791FDA7CE8FB

P31

Q36810980-BBFDC4E5-0DA8-4B94-B6E8-BA8CAB7FBF7D

P356

Q36810980-8DD06CA8-1D69-4E70-A2DE-CFDB25155AFE

P433

Q36810980-B5991414-3B2B-4799-A9B6-90A357E257FB

P478

Q36810980-8DC62A5E-E50F-48C7-98E3-6BBB9BE54E29

P577

Q36810980-DF4740D6-E24D-456B-BE2D-07C45921CC3D

P698

Q36810980-814C11D4-7F5E-487D-AEFA-EB0B20467F8C

P932

Q36810980-25B773B5-C8E4-43C8-A0C8-341F39C41E09

P356

J.JNEUROIM.2013.01.002

P1433

Journal of Neuroimmunology

P1476

Systemic immune system alterations in early stages of Alzheimer's disease.

@en

P2093

Catherine Madison

http://www.w3.org/2001/XMLSchema#string

Dallas A Forshew

http://www.w3.org/2001/XMLSchema#string

Jonathan Katz

http://www.w3.org/2001/XMLSchema#string

Michael S McGrath

http://www.w3.org/2001/XMLSchema#string

Robert G Miller

http://www.w3.org/2001/XMLSchema#string

Ronald Honrada

http://www.w3.org/2001/XMLSchema#string

Rongzhen Zhang

http://www.w3.org/2001/XMLSchema#string

Will Harris

http://www.w3.org/2001/XMLSchema#string

Xia Jin

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

Absence of monocyte chemoattractant protein 1 in mice leads to decreased local macrophage recruitment and antigen-specific T helper cell type 1 immune response in experimental autoimmune encephalomyelitis

Serum MCP-1 levels are increased in mild cognitive impairment and mild Alzheimer's disease.

Chemokines and chemokine receptors in the CNS: a possible role in neuroinflammation and patterning.

Identification of peripheral inflammatory markers between normal control and Alzheimer's disease.

Circulating endotoxin and systemic immune activation in sporadic amyotrophic lateral sclerosis (sALS).

The CD14+ CD16+ blood monocytes: their role in infection and inflammation.

The role of macrophage/microglia and astrocytes in the pathogenesis of three neurologic disorders: HIV-associated dementia, Alzheimer disease, and multiple sclerosis.

How to get from here to there: macrophage recruitment in Alzheimer's disease

Three or more routes for leukocyte migration into the central nervous system.

P304

38-42

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JNEUROIM.2013.01.002

http://www.w3.org/2001/XMLSchema#string

P433

1-2

http://www.w3.org/2001/XMLSchema#string

P478

256

http://www.w3.org/2001/XMLSchema#string

P577

2013-02-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23380586

http://www.w3.org/2001/XMLSchema#string

P932

3641776

http://www.w3.org/2001/XMLSchema#string